Skip to content

Insider · CIK 0001804460

Richard A. Paulson

ceopresidentofficerdirector

Files at BLUE (bluebird bio, Inc.), KPTI (Karyopharm Therapeutics Inc.). First filing Nov 6, 2024, latest Sep 16, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $96k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

KPTI: Karyopharm Therapeutics Inc.

KPTIOct 9, 2026 · close 0.61

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
KPTIsell 6
Karyopharm Therapeutics Inc.
$8,083
1,257 shares
-1%+77% from low-58% from high
33Weak
KPTIsell 2
Karyopharm Therapeutics Inc.
$1,680
236 shares
-0%+77% from low-58% from high
25Weak
KPTIsell
Karyopharm Therapeutics Inc.
$916
245 shares
-0%+9% from low-74% from high
53Moderate
KPTIsell 6
Karyopharm Therapeutics Inc.
$74k
11,694 shares
-12%-
33Weak
KPTIsell 2
Karyopharm Therapeutics Inc.
$2,664
4,099 shares
-0%-
25Weak
KPTIsell
Karyopharm Therapeutics Inc.
$3,175
4,055 shares
-0%-
25Weak
KPTIsell
Karyopharm Therapeutics Inc.
$2,932
3,620 shares
-0%-
25Weak
KPTIsell
Karyopharm Therapeutics Inc.
$3,346
3,675 shares
-0%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 15, 2025KPTI
Karyopharm Therapeutics Inc.
AGrant or award
Common Stock
+114,285$0.00$0198,331Oct 16, 2025
Sep 12, 2025KPTI
Karyopharm Therapeutics Inc.
AGrant or award
Common Stock
+2,800$0.00$085,303Sep 16, 2025
Sep 15, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-1,257$6.43$8,08384,046Sep 16, 2025
May 30, 2025BLUE
bluebird bio, Inc.
UTender of shares
Common Stock
-155--1,323Jun 3, 2025
Jun 2, 2025BLUE
bluebird bio, Inc.
DDisposition to issuer
Common Stock
-1,323--0Jun 3, 2025
May 6, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-236$7.12$1,68082,503May 7, 2025
Apr 4, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-245$3.74$91682,739Apr 7, 2025
Mar 4, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-11,694$6.29$74k82,984Mar 6, 2025
Feb 28, 2025KPTI
Karyopharm Therapeutics Inc.
AGrant or award
Common Stock
+20,000$0.00$094,678Mar 4, 2025
Feb 28, 2025KPTI
Karyopharm Therapeutics Inc.
AGrant or award
Stock Option (right to buy)derivative
+40,000$0.00$040,000Mar 4, 2025
Feb 4, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-4,099$0.65$2,6641,120,158Feb 5, 2025
Jan 6, 2025KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-4,055$0.78$3,1751,124,257Jan 7, 2025
Dec 4, 2024KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-3,620$0.81$2,9321,128,312Dec 5, 2024
Nov 6, 2024BLUE
bluebird bio, Inc.
AGrant or award
Common Stock
+24,900$0.00$029,563Nov 8, 2024
Nov 6, 2024BLUE
bluebird bio, Inc.
AGrant or award
Stock Option (right to buy)derivative
+49,850$0.00$049,850Nov 8, 2024
Nov 5, 2024KPTI
Karyopharm Therapeutics Inc.
SOpen-market sale
Common Stock
-3,675$0.91$3,3461,131,932Nov 6, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Richard A. Paulson: insider trades and track record | InsiderTell